Abstract PS1-07-17: Real-world safety of concurrent pembrolizumab and radiotherapy in triple-negative breast cancer
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Institutions: Institut Curie, Institute Mutualiste Montsouris
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129222124
Cites:
Cited by:
Related to:
